Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Gross Profit Over TimeStrong
Percentile Rank73
3Y CAGR-14.7%
5Y CAGR+7.2%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-14.7%/yr
vs +89.9%/yr prior
5Y CAGR
+7.2%/yr
Recent deceleration
Acceleration
-104.7pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$41.34M-9.8%
2025$45.83M-6.6%
2024$49.05M-26.4%
2023$66.63M+32.5%
2022$50.28M+72.2%
2021$29.20M+50.9%
2020$19.35M+278.1%
2019$5.12M+218.0%
2018$1.61M-10.8%
2017$1.80M-